Atlas Trials

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

Clinical trial NCT04898907 · UNKNOWN

Trial details

NCT number
NCT04898907
Sponsor
Angion Biomedica Corp
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2021-06-01
Primary completion
2021-09-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.